Patent details

Basic Information

Publication number:

EP2763663

PCT Application Number:

EP2012069541

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP127669901

PCT Publication Number:

WO2013050419

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

PHARMACEUTICAL COMPOSITIONS COMPRISING 40-O-(2-HYDROXY)ETHYL-RAPAMYCIN

French Title of Invention:

COMPOSITIONS PHARMACEUTIQUES COMPRENANT 40-O-(2-HYDROXY)ÉTHYL-RAPAMYCINE

German Title of Invention:

PHARMAZEUTISCHE ZUSAMMENSETZUNGEN MIT 40-O-(2-HYDROXY)ETHYL-RAPAMYCIN

SPC Number:

Dates

Filing date:

03/10/2012

Grant date:

27/12/2017

EP Publication Date:

13/08/2014

PCT Publication Date:

11/04/2013

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

27/12/2017

EP B1 Publication Date:

27/12/2017

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

03/10/2018

Expiration date:

03/10/2032

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

20/12/2017

 

 

Name:

Novartis AG

Address:

Lichtstrasse 35, 4056 Basel, Switzerland (CH)

Inventor

1

Name:

CHEUNG, Wing

Address:

United States (US)

2

Name:

LIECHTI, Kurt

Address:

Switzerland (CH)

3

Name:

KUEHL, Peter

Address:

Switzerland (CH)

4

Name:

DIEDERICH, Anke

Address:

Switzerland (CH)

Priority

Priority Number:

201161544026 P

Priority Date:

06/10/2011

Priority Country:

United States (US)

Classification

IPC classification:

A61K 9/20; A61K 9/50; A61K 31/436;

Publication

European Patent Bulletin

Issue number:

201752

Publication date:

27/12/2017

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages
28/02/2019	Outgoing Correspondence	1